OTC · Analyst Forecast

Eurofins Scientific SE (ERFSF) Analyst Forecast

$81.74 OTC: ERFSF Market Cap $14.14B

Revenue and earnings estimates published by analysts covering Eurofins Scientific SE (ERFSF), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Eurofins Scientific SE, analysts forecast revenue rising from $6958.17T in 2024 to $8946.92T in 2029; the average estimate for 2029 earnings per share is $5.44; with published estimates ranging from $5.07 to $5.61; 13 analysts contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD millions)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2024$6591.62T$6958.17T$7118.57T7
2025$6920.17T$7304.99T$7473.38T7
2026$7016.08T$7406.23T$7576.96T7
2027$7179.10T$7814.46T$8188.79T13
2028$7851.86T$8288.49T$8479.57T7
2029$8475.61T$8946.92T$9153.17T11

Earnings per share forecast

YearLowAverageHighAnalysts
2024$2.83$3.04$3.137
2025$3.31$3.56$3.667
2026$3.52$3.78$3.897
2027$3.99$4.29$4.4213
2028$4.46$4.78$4.937
2029$5.07$5.44$5.6111

Eurofins Scientific SE (ERFSF) forecast — frequently asked questions

What are analysts forecasting for Eurofins Scientific SE's earnings?

The average analyst estimate for Eurofins Scientific SE (ERFSF) earnings per share in 2029 is 5.44, with individual estimates between 5.07 and 5.61.

How much revenue is Eurofins Scientific SE expected to make?

Analysts forecast Eurofins Scientific SE (ERFSF) revenue of $8946.92T in 2029, based on 11 published estimates.

How many analysts cover ERFSF?

13 analysts contribute estimates for Eurofins Scientific SE (ERFSF). Thin coverage makes an average less reliable.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.